Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors

por An, Ho Jung, Chon, Hong Jae, Kim, Chan
Publicado 2021

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors

por Oh, Chang-Myung, Chon, Hong Jae, Kim, Chan
Publicado 2020

Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer

por Kim, Chang Woo, Chon, Hong Jae, Kim, Chan
Publicado 2021

Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?

por Lee, Choong-kun, Chan, Stephen L., Chon, Hong Jae
Publicado 2022

Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

por Lee, Won Suk, Yang, Hannah, Chon, Hong Jae, Kim, Chan
Publicado 2020

Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c-MET Amplification

por Sang, Yun Beom, Kim, Gwangil, Hwang, Sohyun, Kang, Haeyoun, Chon, Hong Jae
Publicado 2023

Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach

por Kim, Chang-Gon, Sang, Yun-Beom, Lee, Ji-Hyun, Chon, Hong-Jae
Publicado 2021

A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life...

por Jung, Ji Yoon, Chon, Hong Jae, Choi, Young Jin, Yeon, Sang Eun, Choi, Seok Young, Lee, Kyung Hee
Publicado 2022

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma

por Kim, Youngun, Yang, Hannah, Lee, Won Suk, Cheon, Jaekyung, Sang, Yun Beom, Kang, Beodeul, Chon, Hong Jae, Kim, Chan
Publicado 2023

Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer

por Kim, Chan, Chon, Hong Jae, Kang, Beodeul, Kim, Kiyeol, Jeung, Hei-Cheul, Chung, Hyun Cheol, Noh, Sung Hoon, Rha, Sun Young
Publicado 2013

Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients

por Lim, Sun Min, Kim, Youn Nam, Park, Ki Hyun, Kang, Beodeul, Chon, Hong Jae, Kim, Chan, Kim, Joo Hoon, Rha, Sun Young
Publicado 2016

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

por Cheon, Jaekyung, Kim, Hyeyeong, Kim, Han Sang, Kim, Chang Gon, Kim, Ilhwan, Kang, Beodeul, Kim, Chan, Jung, Sanghoon, Ha, Yeonjung, Chon, Hong Jae
Publicado 2023

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study

por Kim, Beom Kyung, Cheon, Jaekyung, Kim, Hyeyeong, Kang, Beodeul, Ha, Yeonjung, Kim, Do Young, Hwang, Seong Gyu, Chon, Young Eun, Chon, Hong Jae
Publicado 2022

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment

por Chon, Young Eun, Cheon, Jaekyung, Kim, Hyeyeong, Kang, Beodeul, Ha, Yeonjung, Kim, Do young, Hwang, Seong Gyu, Chon, Hong Jae, Kim, Beom Kyung
Publicado 2022

Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis

por Kim, Chan, Yang, Hannah, Park, Intae, Chon, Hong Jae, Kim, Joo Hoon, Kwon, Woo Sun, Lee, Won Suk, Kim, Tae Soo, Rha, Sun Young
Publicado 2016

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy

por Go, Eun-Jin, Yang, Hannah, Chon, Hong Jae, Yang, DaSom, Ryu, WonHyoung, Kim, Dong-Hyun, Han, Dong Keun, Kim, Chan, Park, Wooram
Publicado 2020

PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis

por Go, Eun-Jin, Yang, Hannah, Lee, Seung Joon, Yang, Hyun Gul, Shin, Jin A., Lee, Won Suk, Lim, Hye Seong, Chon, Hong Jae, Kim, Chan
Publicado 2023

The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients

por Lee, Choong-kun, Chon, Hong Jae, Kwon, Woo Sun, Ban, Hyo-Jeong, Kim, Sang Cheol, Kim, Hyunwook, Jeung, Hei-Cheul, Chung, Jimyung, Rha, Sun Young
Publicado 2022

Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma

por Kim, Chan, Yang, Hannah, Kim, Ilhwan, Kang, Beodeul, Kim, Hyeyeong, Kim, Hyunho, Lee, Won Suk, Jung, Sanghoon, Lim, Ho Yeong, Cheon, Jaekyung, Chon, Hong Jae
Publicado 2022

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma

por Sang, Yun Beom, Yang, Hannah, Lee, Won Suk, Lee, Seung Joon, Kim, Seul-Gi, Cheon, Jaekyung, Kang, Beodeul, Kim, Chang Woo, Chon, Hong Jae, Kim, Chan
Publicado 2022